STEMCELL Technologies, Canada’s largest biotechnology company, is marking its 30th year of accelerating research into cancer and other diseases by celebrating its culture of collaboration, curiosity, and discovery.
European Commission greenlights Mirati’s Krazati in KRAS-mutated NSCLC – Pharmaceutical Technology
Share this article Krazati is forecast to generate $1.24bn in sales in 2029, according to GlobalData. Credit: gorodenkoff via Getty Images. Mirati Therapeutics has received